ScienceMed®

Fortificadores de Leite Humano com Proteína Derivada de Aminoácido versus Proteína Derivada de Bovinos em Lactentes Pré-termos em Gestation <34 Semanas: Um Ensaio Controlado Aleatório Piloto de Label Aberto

Endocrinologia
Imagem de arquivo, ilustrativa — não é do estudo. Radiografia da mão de uma criança de 4 anos (Viena, 1896). Josef Maria Eder e Eduard Valenta · CC0 · Wikimedia Commons

Ensaio clínico randomizadoNível 2 · Nova evidênciaNutrients4 ago 20260 citações

Salvar

Resumo original em inglês

O que aconteceu

Bovine milk protein-based human milk fortifiers (HMFs) are routinely used in preterm infants in low- and middle-income countries (LMICs) but are associated with potential adverse effects. Plant-derived amino acid-based HMFs are a promising alternative, but comparative data from randomized controlled trials (RCTs) are lacking. This pilot RCT aimed to evaluate the feasibility, safety, and growth outcomes of a novel plant-derived amino acid-based HMF compared to a bovine-derived whole-protein-based HMF in preterm infants at &lt;34 weeks' gestation.

In this open-label, parallel pilot RCT, preterm infants at &lt;34 weeks' gestation were randomized to a plant-derived amino acid-based HMF (n = 66) or a bovine-derived whole-protein-based HMF (n = 70). Primary outcomes were time to reach 180 mL/kg/d enteral feeds and growth velocities to discharge and 40 weeks' postmenstrual age (PMA). Feasibility and safety were also assessed. The analysis followed an intention-to-treat approach. The trial was registered (CTRI/2025/06/089133).

O que encontraram

Baseline characteristics were comparable between groups. Times to reach enteral feeds of 180 mL/kg/d did not differ (adjusted Hazard Ratio 0.93, 95% CI 0.65, 1.33; p = 0.70). In-hospital weight gain was significantly higher in the plant-derived HMF group (adjusted mean difference (aMD) 3.20 g/kg/d, 95% CI 0.46, 5.95; p = 0.02). This benefit was most evident in subgroup analyses of infants with birth weight ≥1500 g (aMD 4.47 g/kg/d, 95% CI 0.09, 8.84; p = 0.04). Length, head circumference growth, and all safety outcomes were similar between groups.

Por que isso importa

The plant-derived amino acid-based HMF demonstrated clinical feasibility and was well-tolerated. While it was associated with better in-hospital weight gain, differences in overall macronutrient density between the formulations may account for this finding. These results are hypothesis-generating and warrant future adequately powered trials.

Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.

O estudo original

Plant-Derived Amino Acid-Based vs. Bovine-Derived Protein Human Milk Fortifiers in Preterm Infants at <34 Weeks' Gestation: An Open-Label Pilot Randomized Controlled Trial

Nikhil Kumar Mudmal, Viraraghavan Vadakkencherry Ramaswamy, Nasreen Banu Shaik, Laxman Basany, Abid Ali Hasan Ali, V Sree Ramya

Descritores MeSH

  • Amino Acids
  • Food, Fortified
  • Infant, Premature
  • Milk Proteins
  • Milk, Human
  • Infant Formula
  • Pilot Projects
  • Gestational Age
  • Humans
  • Infant Nutritional Physiological Phenomena

Veja também